Roche broadens cervical cancer offering with €190m mtm buy
This article was originally published in Scrip
Executive Summary
Roche is consolidating its presence in the cervical cancer testing market by acquiring mtm laboratories, a privately-held German firm specialising in tests to detect precancerous cervical lesions.